Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | cytochrome B | 0.0521 | 0.5 | 0.5 |
Schistosoma mansoni | cytochrome b | 0.0521 | 0.5 | 0.5 |
Toxoplasma gondii | cytochrome b | 0.0521 | 0.5 | 0.5 |
Schistosoma mansoni | cytochrome b | 0.0521 | 0.5 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | cytochrome b subunit of the bc complex | 0.0521 | 0.5 | 0.5 |
Plasmodium falciparum | cytochrome b | 0.0521 | 0.5 | 0.5 |
Loa Loa (eye worm) | cytochrome b | 0.0521 | 0.5 | 0.5 |
Toxoplasma gondii | apocytochrome b, putative | 0.0521 | 0.5 | 0.5 |
Plasmodium vivax | cytochrome b | 0.0521 | 0.5 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.